ECGI Issues Shareholder Update Letter From the CEO
16 févr. 2022 08h00 HE
|
ECGI Holdings, Inc.
LOS ANGELES, Feb. 16, 2022 (GLOBE NEWSWIRE) -- via InvestorWire – ECGI HOLDINGS INC. (OTC: ECGI) (“ECGI” or the “Company”), D/B/A Elite Cannabis Group Incorporated, a Nevada-based portfolio company...
Grapefruit USA, Inc. Comments on the NFL’s Recent $1 Million Award to Study the Use of Cannabis and CBD to Manage Pain
08 févr. 2022 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Green Nexus is the First Authorized United States Distributor of Barneys Farm Seeds
08 févr. 2022 05h00 HE
|
Green Nexus
HOLLYWOOD, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Green Nexus is the first authorized United States distributor of Barneys Farm seeds, one of the world's most recognized, awarded, and reputable...
Dyadic Introduces Novel Method to Produce Synthetic Cannabinoids and Precursors Utilizing C1 Cell Line Production Platform and Patent Pending Process
20 janv. 2022 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further...
Grapefruit USA, Inc. Announces NNCP Submission to Health Canada to Enable Canada-Wide Sale of Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream
20 janv. 2022 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
InMed Launches Cannabicitran (CBT), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector
19 janv. 2022 07h30 HE
|
InMed Pharmaceuticals Inc.
CBT is the first of several rare cannabinoid launches planned for the first half of 2022; includes CBDV and THCVExpands the Company’s rare cannabinoid product portfolio, which also includes...
Registration Now Open For Tribe Public’s Webinar Event "Addressing The Increasing Demand For Rare Cannabinoids" Featuring InMed’s Management Team On January 6, 2022
30 déc. 2021 07h30 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization...
InMed Pharmaceuticals Announces Publication of Peer-Reviewed Article on the Use of CBN as a Potential Treatment for Glaucoma
20 déc. 2021 07h30 HE
|
InMed Pharmaceuticals Inc.
VANCOUVER, British Columbia, Dec. 20, 2021 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the development, manufacturing and commercialization...
Grapefruit USA, Inc. Announces Hourglass™ Time Release THC+CBD Delivery Cream Is Now Available on Blitzdirect.com Mobile Delivery Platform
08 déc. 2021 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Dec. 08, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premier California-based...
Cannabistry’s Four Proprietary Canna-Tech Platforms Solve Industry Pain Points
02 déc. 2021 06h00 HE
|
Cannabistry
SANTA ROSA, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- Cannabistry, the cannabis leader in world-class Research & Development, trusted products and reliable brand names, has developed four...